BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

HitGen Launches Upgraded OpenDEL™ Kit in China to Enhance Drug Discovery Research.

OpenDEL™ is a self-service DNA-encoded library (DEL) kit, which enables users to explore DEL selection campaigns without revealing the target identit...

June 27, 2023 | News

Innovent and RemeGen Collaborate on Clinical Trial for Combined Therapy of TYVYT® and Novel ADCs in China

Under the agreement, Innovent will provide clinical drug supplies of TYVYT® (sintilimab injection) during the clinical trial collaboration. RemeGen wil...

June 26, 2023 | News

Brii Biosciences to Sell Equity Interest in Qpex Biopharma and Acquire Global Rights for BRII-693

Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...

June 26, 2023 | News

Everest Medicines' Partner Calliditas Presents Nefecon Data at ERA-EDTA Congress

The presentations showed data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon in patients with IgA nephropathy (IgAN). The study m...

June 21, 2023 | News

AstraZeneca Collaborates with Cholesgen for Hypercholesterolemia Drug Discovery and Licensing Agreement

This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...

June 19, 2023 | News

SeekIn paves the way for cancer early detection in low- and middle-income countries

The overall accuracy of TOO prediction in the true positives is 66.8%, which may be supportive in the clinical diagnostic workup. OncoSeek® ...

June 19, 2023 | News

FDA Approves Phase I/II Trial for Leads Biolabs' Anti-MUC16/CD3 Bispecific Antibody in Advanced Solid Tumors.

The study is a multicenter, open-label, dose-escalation and expansion phase Ⅰ/Ⅱ clinical study. The phase Ⅰ part aims to evaluate the safety, to...

June 19, 2023 | News

EW Group Partners with China's Sinopharm, the Largest Healthcare Provider.

EW Group represented by Chairman, Prof. Dato' Sri Dr Mike Chan, and HK VJM Ltd was represented by Mr Guo Liang, while NCL Solutions Sdn Bhd repre...

June 15, 2023 | News

MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China

"The initiation of our FIH clinical trial with MDR-001 is an important milestone for MindRank which is yet another great validation of the potential of our...

June 15, 2023 | News

C2 PHARMA Receives Approval for Digoxin China DMF, Becoming China’s Only European Supplier of This API

C2 Pharma the global leader in manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the appro...

June 14, 2023 | News

Zhongchao Inc. Launches Digital Education Platform for Common Disease Diagnosis and Treatment

This Platform is designed to elevate the clinical decision-making acumen and patient service capabilities of healthcare professionals, thereby delivering o...

June 13, 2023 | News

Eccogene Raises CNY 180M in Series B Financing for Metabolic Disease Treatments

Eccogene Inc., a clinical-stage biotechnology company developing innovative therapeutic solutions for metabolic diseases, announced a CNY 1...

June 12, 2023 | News

China Approves World's First Vaccine for XBB Descendent Lineages of SARS-CoV-2

WestVac Biopharma and its subsidiary company WestVac Biopharma (Guangzhou) leveraged the rapid response of the insect cell expression platform on construct...

June 12, 2023 | News

Dizal Highlights Oncology Pipeline Strength at 2023 ASCO, Leading China's Biotech Innovation

Two highly anticipated oral presentations captured attention: first pivotal study of sunvozertinib (WU-KONG6) and multinational pivotal study of golidoci...

June 08, 2023 | News

Stay Connected